Aspen Aerogels (ASPN) Misses Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Aspen Aerogels (ASPN) PT Lowered to $6 at Needham & Company Following 4Q Report
February 24, 2017 5:48 AM ESTNeedham & Company analyst Sean Hannan reiterates Buy rating and lowers price target on Aspen Aerogels Inc. (NYSE: ASPN) to $6 (from $8), suggesting a challenging year ahead, as the company reported 2016 fourth quarter revenues and EPS below consensus estimates, while margins dropped on lost... More
